Top Markets
Coin of the day
Verici Dx plc Verici Dx plc

Verici Dx plc

VRCI
Rank in Stocks #41055
Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney... Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney transplantation sector. The firm specializes in creating both predictive and diagnostic assays for patients who have undergone kidney transplants. Its development pipeline features Clarava, a pre-transplant tool designed to forecast the likelihood of early acute rejection; Tuteva, a post-transplant assessment focusing on acute cellular rejection; and Protega, an innovative liquid biopsy aiming to predict the risk of fibrosis and eventual graft failure. Established in 2020, Verici Dx plc maintains its headquarters in Penarth, United Kingdom.
Share Price
$0.00285747
Market Cap
$47.76K
Change (1 day)
-16.00%
Change (1 year)
-59.77%
Country
GB
Trade Verici Dx plc (VRCI)

Category

Stock split history for Verici Dx plc (VRCI)
Verici Dx plc stock (symbol: VRCI) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 14, 2026.
One VRCI share bought prior to Aug 14, 2026 would equal to 0 VRCI shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US